MS67 is more effective than WDR5 inhibitors in effectively and selectively depleting WDR5, inhibiting transcription of WDR5 regulatory genes, reducing MLL complex components and chromatin binding parts of c-MYC, and inhibiting the proliferation of cancer cells. This evidence concerns the gene MYC and cancer.